Among the most prescribed drugs of our era, GLP-1 medications like liraglutide are reshaping bodies and metabolisms — yet the inner ecosystem of the gut, it turns out, may only bend temporarily to their influence. A controlled mouse study found that while liraglutide meaningfully reorganized gut bacterial communities during treatment, favoring lactic acid producers and suppressing fermentative species, most of those changes reversed within a week of stopping the drug. The finding invites a deeper question: if the microbiome is merely a temporary passenger on the GLP-1 journey rather than a las